Bacterial Pneumonia
📧 Sign up to get email alerts when something new happens for Bacterial Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Systematic Search for Primary Immunodeficiency in Adults With Infections [NA]
This is a completed clinical trial update for NCT02972281, describing a systematic search to identify primary immunodeficiency in adults wit…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years [Phase 1]
Phase 1 clinical trial update evaluating the safety and immune response of GlaxoSmithKline's investigational pneumococcal vaccine in adults …
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Patients With Hospital-acquired Pneumonia [NA]
This clinical trial update reports on evaluating a DNA-based strategy to tailor antibiotic therapy for patients with hospital-acquired pneum…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection
This clinical trial update describes a post-marketing study evaluating intravenous Polymyxin B and Colistin Methanesulfonate for carbapenem-…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age [Phase 1]
Phase 1 study to evaluate the safety and reactogenicity of an investigational pneumococcal vaccine in infants after a 3-dose primary series …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-11-21EMA Authorised: Invanz (ertapenem sodium) — Merck Sharp & Dohme B.V.
The European Medicines Agency authorised Invanz (ertapenem sodium) by Merck Sharp & Dohme B.V. for a range of infections including community…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Urine Pneumococcal Antigen Project
A clinical trial update from Liverpool School of Tropical Medicine describes a urine pneumococcal antigen project for pneumonia that is not …
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia.
A clinical trial is evaluating different methods of inhaled aerosolized polymyxin B to treat pneumonia caused by carbapenem-resistant gram-n…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Urease Breath Test for Rapid Characterization of Pneumonia
Completed clinical trial evaluating a urease breath test for rapid characterization of pneumonia, with results posted.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP) [Phase 4]
This clinical trial update describes a Phase 4 study evaluating the efficacy and safety of faropenem in Bangladeshi adults with community-ac…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Antimicrobial Therapeutic Drug Monitoring During Lung Transplant Perioperative Phase
This clinical trial update describes a study evaluating antimicrobial therapeutic drug monitoring during the perioperative period of lung tr…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia [Phase 3]
Phase 3 trial comparing omadacycline to moxifloxacin for community-acquired bacterial pneumonia has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Evaluation of Current Practice of Antimicrobial Use and Clinical Outcome in the Management of Pneumonia Among Pediatric Patients Admitted to Jimma Medical Center, Southwest Ethiopia: A Prospective Observational Study
This completed prospective observational study from Jimma Medical Center evaluated current antimicrobial prescribing practices and clinical …
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Study of Leukocyte Immunophenotype and the Lipid Transport System as Predictive Biomarkers of Severe Bacterial Infections
This clinical trial update notes that enrollment is ongoing for a study evaluating whether leukocyte immunophenotype and lipid transport sys…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101 [Phase 1]
A first-in-human Phase 1 study of CMTX-101 in pneumonia was terminated, with no completed safety, tolerability, pharmacokinetics, or immunog…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Fosfomycin I.v. for Treatment of Severely Infected Patients
An intravenous fosfomycin trial is recruiting to evaluate its use in severely infected patients across multiple bacterial infection indicati…
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Pediatric Helmet CPAP Pilot Study [NA]
A pediatric helmet CPAP pilot trial sponsored by Columbia University in children with viral bronchiolitis and pneumonia was terminated; resu…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: CPAP Therapy Through a Helmet or a Full Face Mask in Patients With Acute Hypoxemic Respiratory Failure: Cross-over Study [NA]
A cross-over trial comparing helmet CPAP to full-face mask CPAP in patients with acute hypoxemic respiratory failure; the study status is co…
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients [Phase 3]
Phase 3 clinical trial update for Kunamin in SARS-CoV-2 PCR-positive COVID-19 patients has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Cx611-0204 SEPCELL Study [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial (SEPCELL Study) evaluating Cx611-0204 for bacterial pneumonia, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19 [Phase 2]
Phase 2 trial evaluating oral probiotics for secondary bacterial pneumonia in severe COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia [Phase 1]
Phase 1 trial update reporting cefiderocol concentrations in the lungs of hospitalized patients with bacterial pneumonia; study terminated w…
-
CLINICAL_TRIALS trial_result · 2020-04-16Clinical Trial Update: Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) [Phase 3]
Phase 3 trial comparing imipenem/relebactam/cilastatin to piperacillin/tazobactam for bacterial pneumonia completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Sphingosine-1-phosphate and Pneumonia [Phase 2, Phase 3]
Clinical trial update involving sphingosine-1-phosphate for bacterial pneumonia with Phase 2 and Phase 3 exploration; current status unknown…
-
EMA withdrawal · 2018-05-16EMA Withdrawn: Vibativ (telavancin) — Theravance Biopharma Ireland Umited
The EMA has withdrawn Vibativ (telavancin) from the market in the EU, a drug indicated for bacterial pneumonia and cross-infection.